122 related articles for article (PubMed ID: 33661456)
1. Circulating tumor cells after neoadjuvant chemotherapy are related with recurrence in esophageal squamous cell carcinoma.
Ujiie D; Matsumoto T; Endo E; Okayama H; Fujita S; Kanke Y; Watanabe Y; Hanayama H; Hayase S; Saze Z; Ohki S; Kono K
Esophagus; 2021 Jul; 18(3):566-573. PubMed ID: 33661456
[TBL] [Abstract][Full Text] [Related]
2. Practical value of identifying circulating tumor cells to evaluate esophageal squamous cell carcinoma staging and treatment efficacy.
Chen W; Li Y; Yuan D; Peng Y; Qin J
Thorac Cancer; 2018 Aug; 9(8):956-966. PubMed ID: 29893036
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of detecting circulating tumor cells in patients with esophageal squamous cell carcinoma by EpCAM‑independent enrichment and immunostaining‑fluorescence in situ hybridization.
Zhang Y; Li J; Wang L; Meng P; Zhao J; Han P; Xia J; Xu J; Wang L; Shen F; Zheng A; Zhou F; Fan R
Mol Med Rep; 2019 Aug; 20(2):1551-1560. PubMed ID: 31257510
[TBL] [Abstract][Full Text] [Related]
4. Detection of Circulating Tumor Cells by Fluorescent Immunohistochemistry in Patients with Esophageal Squamous Cell Carcinoma: Potential Clinical Applications.
Li SP; Guan QL; Zhao D; Pei GJ; Su HX; Du LN; He JX; Liu ZC
Med Sci Monit; 2016 May; 22():1654-62. PubMed ID: 27184872
[TBL] [Abstract][Full Text] [Related]
5. Detection of Epithelial-Mesenchymal Transition Status of Circulating Tumor Cells in Patients with Esophageal Squamous Carcinoma.
Han D; Chen K; Che J; Hang J; Li H
Biomed Res Int; 2018; 2018():7610154. PubMed ID: 30046606
[TBL] [Abstract][Full Text] [Related]
6. Clinical Significance of TWIST-Positive Circulating Tumor Cells in Patients with Esophageal Squamous Cell Carcinoma.
Lee HJ; Kim GH; Park SJ; Kwon CH; Lee MW; Lee BE; Baek DH; I H
Gut Liver; 2021 Jul; 15(4):553-561. PubMed ID: 33293482
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of tumor cells in the peripheral blood of patients with esophageal squamous cell carcinoma.
Han L; Li YJ; Zhang WD; Song PP; Li H; Li S
Medicine (Baltimore); 2019 Feb; 98(6):e13921. PubMed ID: 30732126
[TBL] [Abstract][Full Text] [Related]
8. Liquid Biopsy: Detection of Circulating Tumor Cells in Esophageal Squamous Cell Carcinoma.
Lam AK; Hamid FB; Gopalan V
Methods Mol Biol; 2020; 2129():193-202. PubMed ID: 32056179
[TBL] [Abstract][Full Text] [Related]
9. GR, Sgk1, and NDRG1 in esophageal squamous cell carcinoma: their correlation with therapeutic outcome of neoadjuvant chemotherapy.
Ueki S; Fujishima F; Kumagai T; Ishida H; Okamoto H; Takaya K; Sato C; Taniyma Y; Kamei T; Sasano H
BMC Cancer; 2020 Feb; 20(1):161. PubMed ID: 32106831
[TBL] [Abstract][Full Text] [Related]
10. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
[TBL] [Abstract][Full Text] [Related]
11. In vivo detection demonstrates circulating tumor cell reduction instead of baseline number has prognostic value in bladder cancer patients receiving neoadjuvant chemotherapy.
Jin D; Qian L; Xia J; Zhang R; Yang G; Zhang L; Xue W; Cao M; Dong L; Chen H
Cell Oncol (Dordr); 2023 Jun; 46(3):793-797. PubMed ID: 36877311
[TBL] [Abstract][Full Text] [Related]
12. Circulating tumor cells detected using fluid-assisted separation technique in esophageal squamous cell carcinoma.
Choi MK; Kim GH; I H; Park SJ; Lee MW; Lee BE; Park DY; Cho YK
J Gastroenterol Hepatol; 2019 Mar; 34(3):552-560. PubMed ID: 30426559
[TBL] [Abstract][Full Text] [Related]
13. Immuno-genomic profiling of biopsy specimens predicts neoadjuvant chemotherapy response in esophageal squamous cell carcinoma.
Sasagawa S; Kato H; Nagaoka K; Sun C; Imano M; Sato T; Johnson TA; Fujita M; Maejima K; Okawa Y; Kakimi K; Yasuda T; Nakagawa H
Cell Rep Med; 2022 Aug; 3(8):100705. PubMed ID: 35944530
[TBL] [Abstract][Full Text] [Related]
14. Influence of incomplete neoadjuvant chemotherapy on esophageal carcinoma.
Fujiwara Y; Lee S; Kishida S; Hashiba R; Gyobu K; Naka R; Nishiyama M; Ihara T; Takemura M; Osugi H
Int J Clin Oncol; 2018 Oct; 23(5):877-885. PubMed ID: 29752605
[TBL] [Abstract][Full Text] [Related]
15. Monitoring disease progression and treatment efficacy with circulating tumor cells in esophageal squamous cell carcinoma: A case report.
Qiao YY; Lin KX; Zhang Z; Zhang DJ; Shi CH; Xiong M; Qu XH; Zhao XH
World J Gastroenterol; 2015 Jul; 21(25):7921-8. PubMed ID: 26167094
[TBL] [Abstract][Full Text] [Related]
16. EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy.
Le Du F; Fujii T; Kida K; Davis DW; Park M; Liu DD; Wu W; Chavez-MacGregor M; Barcenas CH; Valero V; Tripathy D; Reuben JM; Ueno NT
PLoS One; 2020; 15(3):e0229903. PubMed ID: 32214335
[TBL] [Abstract][Full Text] [Related]
17. Circulating Tumor Cell Analyses in Patients With Esophageal Squamous Cell Carcinoma Using Epithelial Marker-Dependent and -Independent Approaches.
Li H; Song P; Zou B; Liu M; Cui K; Zhou P; Li S; Zhang B
Medicine (Baltimore); 2015 Sep; 94(38):e1565. PubMed ID: 26402816
[TBL] [Abstract][Full Text] [Related]
18. Simple Cancer Stem Cell Markers Predict Neoadjuvant Chemotherapy Resistance of Esophageal Squamous Cell Carcinoma.
Agawa K; Yamashita K; Nakagawa A; Yamada K; Watanabe A; Mukohyama J; Saito M; Fujita M; Takiguchi G; Urakawa N; Hasegawa H; Kanaji S; Matsuda T; Oshikiri T; Nakamura T; Suzuki S; Kakeji Y
Anticancer Res; 2021 Aug; 41(8):4117-4126. PubMed ID: 34281882
[TBL] [Abstract][Full Text] [Related]
19. Expression status of CD44 and CD133 as a prognostic marker in esophageal squamous cell carcinoma treated with neoadjuvant chemotherapy followed by radical esophagectomy.
Okamoto K; Ninomiya I; Ohbatake Y; Hirose A; Tsukada T; Nakanuma S; Sakai S; Kinoshita J; Makino I; Nakamura K; Hayashi H; Oyama K; Inokuchi M; Nakagawara H; Miyashita T; Hidehiro T; Takamura H; Fushida S; Ohta T
Oncol Rep; 2016 Dec; 36(6):3333-3342. PubMed ID: 27748881
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Advantage of Docetaxel/Cisplatin/ 5-Fluorouracil Neoadjuvant Chemotherapy in Clinical Stage II/III Esophageal Squamous Cell Carcinoma due to Excellent Control of Preoperative Disease and Postoperative Lymph Node Recurrence.
Yamashita K; Hosoda K; Moriya H; Katada C; Sugawara M; Mieno H; Komori S; Katada N; Watanabe M
Oncology; 2017; 92(4):221-228. PubMed ID: 28110330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
